More on COX-2s and cardiovascular risk but unlikely to be last word

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1475, 2005-01, pp. : 21-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

More on COX-2s and cardiovascular risk but unlikely to be last word

Reactions Weekly, Vol. 1, Iss. 1039, 2005-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Towards understanding: COX-2s and cardiovascular disorders

Reactions Weekly, Vol. 1, Iss. 1036, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Potential Mechanisms of COX-2 Selective Inhibitors Affecting Cardiovascular Risk

By Smith Howard S.

Journal of Cancer Pain & Symptom Palliation, Vol. 2, Iss. 3, 2008-01 ,pp. : 5-18

Haworth Press

Access to resources Recommend Favorite

Temporal Relationship between Use of NSAIDs, Including Selective COX-2 Inhibitors, and Cardiovascular Risk

By Motsko Stephen P.

Drug Safety, Vol. 29, Iss. 7, 2006-01 ,pp. : 621-632

Adis International

Access to resources Recommend Favorite

Cardiovascular and Renovascular Implications of COX-2 Inhibition

Current Pharmaceutical Design, Vol. 10, Iss. 6, 2004-02 ,pp. : 603-611

Bentham Science Publishers

Access to resources Recommend Favorite